Literature DB >> 19587144

GEC-targeted HO-1 expression reduces proteinuria in glomerular immune injury.

Pu Duann1, Elias A Lianos.   

Abstract

Induction of heme oxygenase (HO)-1 is a key defense mechanism against oxidative stress. Compared with tubules, glomeruli are refractory to HO-1 upregulation in response to injury. This can be a disadvantage as it may be associated with insufficient production of cytoprotective heme-degradation metabolites. We, therefore, explored whether 1) targeted HO-1 expression can be achieved in glomeruli without altering their physiological integrity and 2) this expression reduces proteinuria in immune injury induced by an anti-glomerular basement membrane (GBM) antibody (Ab). We employed a 4.125-kb fragment of a mouse nephrin promoter downstream to which a FLAG-tagged hHO-1 cDNA sequence was inserted and subsequently generated transgenic mice from the FVB/N parental strain. There was a 16-fold higher transgene expression in the kidney than nonspecific background (liver) while the transprotein immunolocalized in glomerular epithelial cells (GEC). There was no change in urinary protein excretion, indicating that GEC-targeted HO-1 expression had no effect on glomerular protein permeability. Urinary protein excretion in transgenic mice with anti-GBM Ab injury (days 3 and 6) was significantly lower compared with wild-type controls. There was no significant change in renal expression levels of profibrotic (TGF-beta1) or anti-inflammatory (IL-10) cytokines in transgenic mice with anti-GBM Ab injury. These observations indicate that GEC-targeted HO-1 expression does not alter glomerular physiological integrity and reduces proteinuria in glomerular immune injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587144      PMCID: PMC2739711          DOI: 10.1152/ajprenal.00213.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  34 in total

1.  Rapid and accurate determination of zygosity in transgenic animals by real-time quantitative PCR.

Authors:  Laurent Tesson; Jean-Marie Heslan; Séverine Ménoret; Ignacio Anegon
Journal:  Transgenic Res       Date:  2002-02       Impact factor: 2.788

2.  Comparison of the heme-free and -bound crystal structures of human heme oxygenase-1.

Authors:  Latesh Lad; David J Schuller; Hideaki Shimizu; Jonathan Friedman; Huiying Li; Paul R Ortiz de Montellano; Thomas L Poulos
Journal:  J Biol Chem       Date:  2002-12-24       Impact factor: 5.157

Review 3.  The role of reactive oxygen metabolites in glomerular disease.

Authors:  S V Shah
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

4.  Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice.

Authors:  Tzong-Shyuan Lee; Lee-Young Chau
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

5.  FVB/N: an inbred mouse strain preferable for transgenic analyses.

Authors:  M Taketo; A C Schroeder; L E Mobraaten; K B Gunning; G Hanten; R R Fox; T H Roderick; C L Stewart; F Lilly; C T Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  [Production of reactive oxygen species and scavenger treatment in nephrotoxic nephritis].

Authors:  K Nakamura
Journal:  Nihon Jinzo Gakkai Shi       Date:  1992-07

7.  Basement membrane-specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane of diabetic rats.

Authors:  K J McCarthy; D R Abrahamson; K R Bynum; P L St John; J R Couchman
Journal:  J Histochem Cytochem       Date:  1994-04       Impact factor: 2.479

8.  Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells.

Authors:  Melina M Ribeiro; Dagmar Klein; Antonello Pileggi; R Damaris Molano; Christopher Fraker; Camillo Ricordi; Luca Inverardi; Ricardo L Pastori
Journal:  Biochem Biophys Res Commun       Date:  2003-06-13       Impact factor: 3.575

Review 9.  Cell biology of the glomerular podocyte.

Authors:  Hermann Pavenstädt; Wilhelm Kriz; Matthias Kretzler
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

10.  Evidence for splicing new basement membrane into old during glomerular development in newborn rat kidneys.

Authors:  D R Abrahamson; E W Perry
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  6 in total

1.  Total bilirubin is negatively related to diabetes mellitus in Chinese elderly: a community study.

Authors:  Ping Zhong; Dongmei Sun; Danhong Wu; Xueyuan Liu
Journal:  Ann Transl Med       Date:  2019-09

2.  Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study.

Authors:  Ali Abbasi; Petronella E Deetman; Eva Corpeleijn; Ron T Gansevoort; Rijk O B Gans; Hans L Hillege; Pim van der Harst; Ronald P Stolk; Gerjan Navis; Behrooz Z Alizadeh; Stephan J L Bakker
Journal:  Diabetes       Date:  2014-11-03       Impact factor: 9.461

3.  In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice.

Authors:  Junghyun Kim; Abolfazl Zarjou; Amie M Traylor; Subhashini Bolisetty; Edgar A Jaimes; Travis D Hull; James F George; Fady M Mikhail; Anupam Agarwal
Journal:  Kidney Int       Date:  2012-04-11       Impact factor: 10.612

4.  Elevated serum urate is a potential factor in reduction of total bilirubin: a Mendelian randomization study.

Authors:  Hui Zhang; Jing Liu; Zheng Dong; Yue Ding; Qiaoxia Qian; Jingru Zhou; Yanyun Ma; Zhendong Mei; Xiangxiang Chen; Yuan Li; Ziyu Yuan; Juan Zhang; Yajun Yang; Xingdong Chen; Li Jin; Hejian Zou; Xiaofeng Wang; Jiucun Wang
Journal:  Oncotarget       Date:  2017-10-24

Review 5.  Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury.

Authors:  Maria G Detsika; Elias A Lianos
Journal:  Antioxidants (Basel)       Date:  2021-01-06

6.  Expression of Ser729 phosphorylated PKCepsilon in experimental crescentic glomerulonephritis: an immunohistochemical study.

Authors:  V N Karavana; H Gakiopoulou; E A Lianos
Journal:  Eur J Histochem       Date:  2014-04-15       Impact factor: 3.188

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.